Rheumatology - Rheumatology Academy

17-32 of 137

Can We Prevent Psoriatic Arthritis Before Diagnosis?
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Living Rheum
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Living Rheum
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Living Rheum
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
- Laura Coates, MBChB, MRCP, PhD
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
CME/CE
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
Flavia Castelino, MD; Benjamin Korman, MD
1.00 credit
- Flavia Castelino, MD
- Benjamin Korman, MD
1.00 credit
Progress and Practical Limits with AI in Psoriatic Arthritis
Progress and Practical Limits with AI in Psoriatic Arthritis
AudioAbstracts
Progress and Practical Limits with AI in Psoriatic Arthritis
Ryan Quigley
- Ryan Quigley
Molecular Signals and Early Detection in Psoriatic Arthritis
Molecular Signals and Early Detection in Psoriatic Arthritis
Living Rheum
Molecular Signals and Early Detection in Psoriatic Arthritis
Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
AudioAbstracts
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Ryan Quigley
- Ryan Quigley
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living Rheum
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD; Marc Scherlinger, MD, PhD
- Steve Jackson, PharmD
- Marc Scherlinger, MD, PhD
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living Rheum
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Ryan Quigley; Luigi Adamo, MD, PhD
- Ryan Quigley
- Luigi Adamo, MD, PhD
- Andrea Fava, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living Rheum
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Gary S. Firestein, MD
- Gary S. Firestein, MD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living Rheum
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
- Gary S. Firestein, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsult
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living Rheum
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Ryan Quigley
- Ryan Quigley
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living Rheum
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living Rheum
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers

2/7